Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Biochemistry ; 48(15): 3457-67, 2009 Apr 21.
Article in English | MEDLINE | ID: mdl-19226146

ABSTRACT

Loss-of-function mutations in calpain 3 have been shown to cause limb-girdle muscular dystrophy type 2A (LGMD2A), an autosomal recessive disorder that results in gradual wasting of the muscles of the hip and shoulder areas. Due to the inherent instability of calpain 3, recombinant expression of the full-length enzyme has not been possible, making in vitro analysis of specific LGMD2A-causing mutations difficult. However, because calpain 3 is highly similar in amino acid sequence to calpain 2, the recently solved crystal structure of full-length, Ca2+-bound, calpastatin-inhibited rat calpain 2 has allowed us to model calpain 3 as a Ca2+-bound homodimer. The model revealed three distinct areas of the enzyme that undergo a large conformational change upon Ca2+ binding. Located in these areas are several residues that undergo mutation to cause LGMD2A. We investigated the in vitro effects of six of these mutations by making the corresponding mutations in rat calpain 2. All six mutations examined in this study resulted in a decrease in enzyme activity. All but one of the mutations caused an increased rate of autoproteolytic degradation of the enzyme as witnessed by SDS-PAGE, indicating the decrease in enzyme activity is caused, at least in part, by an increase in the rate of autoproteolytic degradation. The putative in vivo effects of these mutations on calpain 3 activity are discussed with respect to their ability to cause LGMD2A.


Subject(s)
Calpain/antagonists & inhibitors , Calpain/metabolism , Isoenzymes/antagonists & inhibitors , Isoenzymes/metabolism , Muscle Proteins/antagonists & inhibitors , Muscle Proteins/metabolism , Muscular Dystrophies, Limb-Girdle/enzymology , Amino Acid Sequence , Animals , Calpain/genetics , Calpain/physiology , Enzyme Activation/genetics , Humans , Isoenzymes/genetics , Molecular Sequence Data , Muscle Proteins/genetics , Muscle Proteins/physiology , Muscular Dystrophies, Limb-Girdle/classification , Muscular Dystrophies, Limb-Girdle/genetics , Mutagenesis, Site-Directed , Rats , Sequence Homology, Amino Acid , Time Factors
2.
Nature ; 456(7220): 409-12, 2008 Nov 20.
Article in English | MEDLINE | ID: mdl-19020623

ABSTRACT

Calpains are non-lysosomal calcium-dependent cysteine proteinases that selectively cleave proteins in response to calcium signals and thereby control cellular functions such as cytoskeletal remodelling, cell cycle progression, gene expression and apoptotic cell death. In mammals, the two best-characterized members of the calpain family, calpain 1 and calpain 2 (micro-calpain and m-calpain, respectively), are ubiquitously expressed. The activity of calpains is tightly controlled by the endogenous inhibitor calpastatin, which is an intrinsically unstructured protein capable of reversibly binding and inhibiting four molecules of calpain, but only in the presence of calcium. To date, the mechanism of inhibition by calpastatin and the basis for its absolute specificity have remained speculative. It was not clear how this unstructured protein inhibits calpains without being cleaved itself, nor was it known how calcium induced changes that facilitated the binding of calpastatin to calpain. Here we report the 2.4-A-resolution crystal structure of the calcium-bound calpain 2 heterodimer bound by one of the four inhibitory domains of calpastatin. Calpastatin is seen to inhibit calpain by occupying both sides of the active site cleft. Although the inhibitor passes through the active site cleft it escapes cleavage in a novel manner by looping out and around the active site cysteine. The inhibitory domain of calpastatin recognizes multiple lower affinity sites present only in the calcium-bound form of the enzyme, resulting in an interaction that is tight, specific and calcium dependent. This crystal structure, and that of a related complex, also reveal the conformational changes that calpain undergoes on binding calcium, which include opening of the active site cleft and movement of the domains relative to each other to produce a more compact enzyme.


Subject(s)
Calcium-Binding Proteins/chemistry , Calcium-Binding Proteins/metabolism , Calcium/metabolism , Calpain/antagonists & inhibitors , Calpain/chemistry , Animals , Calpain/metabolism , Catalytic Domain , Crystallography, X-Ray , Models, Molecular , Protein Binding , Protein Multimerization , Rats , Structure-Activity Relationship
3.
FEBS Lett ; 581(16): 2894-8, 2007 Jun 26.
Article in English | MEDLINE | ID: mdl-17543955

ABSTRACT

Calpastatin is the endogenous, specific protein inhibitor of the calcium-dependent protease, calpain. Using an active site knock-out m-calpain mutant we have studied the enzyme's calcium-dependent binding to calpastatin by surface plasmon resonance without the complication of proteolysis. Calpastatin was capable of simultaneously binding four molecules of calpain. Its four inhibitory domains (CAST1, 2, 3, and 4) were individually expressed in Escherichia coli and the kinetics of their interaction with calpain was separately compared. Their K(d) values ranged from picomolar to nanomolar in the order CAST1>4>3>2. They have similar k(on) values but the k(off) values ranged over three orders of magnitude and can account for the differences in affinity.


Subject(s)
Calcium-Binding Proteins/metabolism , Calpain/metabolism , Animals , Calcium-Binding Proteins/chemistry , Calcium-Binding Proteins/isolation & purification , In Vitro Techniques , Kinetics , Models, Biological , Protein Binding , Protein Structure, Tertiary , Rats , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...